Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Dynavax Technologies
(NQ:
DVAX
)
10.14
USD
+0.18 (+1.81%)
Official Closing Price
Updated: 7:52 PM EDT, Apr 14, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,467,500
Open
9.970
Bid (Size)
10.12 (2)
Ask (Size)
10.18 (2)
Prev. Close
9.960
Today's Range
9.930 - 10.56
52wk Range
3.000 - 12.44
Shares Outstanding
100,753,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Positive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate Using Dynavax's CpG 1018™ Adjuvant
April 06, 2021
- VLA2001, an inactivated COVID-19 vaccine candidate with CpG 1018 adjuvant, was highly immunogenic and generally safe and well tolerated
From
PR Newswire
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
April 06, 2021
From
GlobeNewswire News Releases
Performance
YTD
+119.48%
+119.48%
1 Month
-0.69%
-0.69%
3 Month
+99.21%
+99.21%
6 Month
+120.92%
+120.92%
1 Year
+212.00%
+212.00%
More News
Read More
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2021
From
PR Newswire
Effective Diagnostics Help to Tame the Spread of the Pandemic
March 24, 2021
From
PR Newswire
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
March 24, 2021
From
PR Newswire
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
March 24, 2021
From
PR Newswire
COVID-19 Pandemic Still Fueling Need For Increased Supplies & New Technology In PPE Markets
March 23, 2021
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
COVID-19 Pandemic Still Fueling Need For Increased Supplies & New Technology In PPE Markets
March 23, 2021
From
PR Newswire
Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference
March 01, 2021
From
PR Newswire
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2021
From
PR Newswire
Valneva's COVID-19 Vaccine Candidate Using Dynavax's Adjuvant Shows Positive Interim Results
April 06, 2021
Tags
FDA
Small Cap
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.